Comparison of Low Molecular Weight Heparin With Unfractionated Heparin During Percutaneous Coronary Interventions: A Meta-Analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of Low Molecular Weight Heparin With Unfractionated Heparin During Percutaneous Coronary Interventions: A Meta-Analysis

Published:2011-05 Issue:3 Volume:18 Page:180-189
ISSN:1075-2765
Container-title:American Journal of Therapeutics
language:en
Short-container-title:

Author:

Kodumuri Vamsi,Adigopula Sashi,Singh Param,Swaminathan Paari,MD Rohit Arora,Khosla Sandeep

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology,General Medicine

Reference31 articles.

1. A comparison of low molecular weight heparin with unfractionated heparin for unstable coronary artery disease.;Cohen;N Engl J Med,1997

2. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of Thrombolysis In Myocardial Infarction (TIMI) 11B trial.;Antman;Circulation,1999

3. Low-molecular-weight heparin vs. unfractionated heparin in percutaneous coronary intervention: a combined analysis.;Borentain;Catheter Cardiovasc Interv,2005

4. Mechanisms for the antithrombotic activity in man of low molecular weight heparins (LMWHs).;Samama;Haemostasis,1994

5. Enoxaparin versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention (STEEPLE trial).;Montalescot;N Engl J Med,2006

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of low dose or no heparinization in cerebral angiography: A randomized controlled study (SELECT trial);Brain Circulation;2024-09-13

2. Antithrombotische Therapie;Arzneiverordnungs-Report 2023;2023

3. Antithrombotische Therapie;Arzneiverordnungs-Report 2022;2022

4. Antithrombotika und Antihämorrhagika;Arzneiverordnungs-Report 2021;2021

5. Antithrombotika und Antihämorrhagika;Arzneiverordnungs-Report 2020;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3